ReviewDrug design, development and therapy2019

Clinical evaluation of dacomitinib for the treatment of metastatic non-small cell lung cancer (NSCLC): current perspectives.

Daniele Lavacchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.